…psychedelic patents
“…we will vigorously enforce our patents when it comes to commercial competitors,” said Christian Angermayer of Compass Pathways… on [synthetic psilocybin Polymorph A] Comp 360… [although] their IP is actually a lot narrower than it otherwise would have been had that challenge to the patent not have gone through… the Polymorph A patent for Compass…
Recent Comments